Bullish: Don't Fall Into The FOMO Trap — Positive

BLSH   Seeking Alpha — August 14, 2025

Bullish had a highly successful IPO, raising $1.1B which signaled strong investor appetite for crypto assets. The platform offers a comprehensive suite of crypto trading and data services, competing with companies like Binance, Coinbase and Robinhood. Bullish's profitability is tied to crypto market volatility. The firm lost money in Q1'25, but was profitable in the previous two fiscal years.

image for news Bullish: Don't Fall Into The FOMO Trap

5 Discretionary Stocks to Boost Your Portfolio on Rising Rate Cut Hopes — Positive

CCL  DIS  HAS  NFLX  RL   Zacks Investment Research — August 14, 2025

Rate cut optimism is fueling U.S. markets, with DIS, CCL, HAS, NFLX and RL set for potential gains in consumer discretionary.

image for news 5 Discretionary Stocks to Boost Your Portfolio on Rising Rate Cut Hopes

LOS ANGELES , Aug. 14, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against KinderCare Learning Companies, Inc. ("KinderCare" or "the Company") (NYSE: KLC) for violations of the federal securities laws. Investors who purchased the Company's securities pursuant and/or traceable to the Company's Offering Documents issued in connection with its initial public offering ("IPO") conducted in October 2024, are encouraged to contact the firm before October 14, 2025.

image for news KLC Investors Have Opportunity to Lead KinderCare Learning Companies, Inc. Securities Fraud Lawsuit with the Schall Law Firm

FET has a promising strategy that focuses on niche segments. This way, they've gained momentum in 2026 despite rig declines. Q2's revenue came in at the top of their guidance, with an impressive subsea backlog that should give them long-term revenue stability. Their coiled tubing segment also gained in the US and the Middle East, while international sales expanded.

image for news Forum Energy Technologies: Beating The Rig Cycle With Niches And Subsea Backlog

Kelowna, British Columbia – TheNewswire - August 14, 2025 – Lexaria Bioscience Corp. (Nasdaq: LEXX, LEXXW) (the “ Company ” or “ Lexaria ”), a global innovator in drug delivery platforms, is pleased to announce that its Contract Research Organization (“ CRO ”) has completed the important study milestone known as last patent last visit (“ LPLV ”) in Lexaria's Phase 1b glucagon-like peptide-1 (“ GLP-1 ”) study in Australia, GLP-1-H24-4 (the “ Study ”). “We are delighted that this important milestone has been achieved on schedule, concluding all patient dosing and clinical testing in our Study,” said John Docherty, …

image for news Lexaria's Phase 1b GLP-1 Study Achieves Important "Last Patient Last Visit" Milestone

Brinker Serves Up Earnings Beat, Sidesteps Cost Pressures — Positive

EAT   MarketBeat — August 14, 2025

Brinker International Inc. NYSE: EAT stock is surging over 2.5% on strong volume after the company's strong second-quarter earnings report. The company reported strong, 21.3% same-store sales growth for its Chili's and Maggiano's chains.

image for news Brinker Serves Up Earnings Beat, Sidesteps Cost Pressures

KELOWNA, BC / ACCESS Newswire / August 14, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to announce that its Contract Research Organization ("CRO") has completed the important study milestone known as last patent last visit ("LPLV") in Lexaria's Phase 1b glucagon-like peptide-1 ("GLP-1") study in Australia, GLP-1-H24-4 (the "Study"). "We are delighted that this important milestone has been achieved on schedule, concluding all patient dosing and clinical testing in our Study," said John Docherty, Lexaria's President and CSO.

image for news Lexaria's Phase 1b GLP-1 Study Achieves Important "Last Patient Last Visit" Milestone

BigBear.ai Holdings Q2: When Speculation Is Louder Than Fundamentals — Positive

BBAI   Seeking Alpha — August 14, 2025

BigBear.ai Holdings, Inc.'s Q2 '25 results show declining revenue, shrinking margins, and ballooning losses, despite management's optimism and strong cash reserves. The current $5.81 share price reflects speculation, not fundamentals; the stock's 350% rally lacks support from real business progress or profitability. For an upgrade, I need to see reduced cash burn, meaningful new contracts, and tangible revenue from international partnerships in Q3.

image for news BigBear.ai Holdings Q2: When Speculation Is Louder Than Fundamentals

Ideal Power Reports Second Quarter 2025 Financial Results — Neutral

IPWR   PRNewsWire — August 14, 2025

AUSTIN, Texas , Aug. 14, 2025 /PRNewswire/ -- Ideal Power Inc. (Nasdaq: IPWR) ("Ideal Power," the "Company," "we," "us" or "our"), developer and innovative provider of the highly efficient and broadly patented B-TRAN® bidirectional semiconductor power switch, reports results for its second quarter ended June 30, 2025. "Our first design win customer is nearing completion of their B-TRAN®-enabled solid-state circuit breaker (SSCB) prototype testing.

image for news Ideal Power Reports Second Quarter 2025 Financial Results

LOS ANGELES , Aug. 14, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against SelectQuote, Inc. ("SelectQuote" or "the Company") (NYSE: SLQT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between September 9, 2020 and May 1, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before October 10, 2025.

image for news SLQT Investors Have Opportunity to Lead SelectQuote, Inc. Securities Fraud Lawsuit with the Schall Law Firm

ON Semiconductor: The Same Old Battle Between Present And Future — Negative

ON   Seeking Alpha — August 14, 2025

ON Semiconductor Corporation faces persistent margin pressure and underwhelming results despite recent sector-driven volatility and rallies. Q2 earnings results and guidance were largely in line with low expectations, with no meaningful near-term automotive rebound expected. Valuation has deteriorated significantly, with 2027 targets now appearing unachievable and fair value estimates dropping to the mid-$50s.

image for news ON Semiconductor: The Same Old Battle Between Present And Future

Cellebrite DI Ltd. (CLBT) Tops Q2 Earnings and Revenue Estimates — Positive

CLBT   Zacks Investment Research — August 14, 2025

Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.1 per share.

image for news Cellebrite DI Ltd. (CLBT) Tops Q2 Earnings and Revenue Estimates

Canaan (CAN) Reports Q2 Loss, Beats Revenue Estimates — Neutral

CAN   Zacks Investment Research — August 14, 2025

Canaan (CAN) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.15 per share a year ago.

image for news Canaan (CAN) Reports Q2 Loss, Beats Revenue Estimates

Top 3 Materials Stocks Which Could Rescue Your Portfolio This Quarter — Positive

CE  IMTCF  NAMM   Benzinga — August 14, 2025

The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.

image for news Top 3 Materials Stocks Which Could Rescue Your Portfolio This Quarter

Sunrun has further growth potential, according to Wells Fargo. Analyst Michael Blum reaffirmed his overweight rating on the residential solar panel manufacturer and lifted his price target by $6 to $14.

image for news Wells Fargo sees more upside for Sunrun as cash generation outlook holds firm

Welcome to the Green Stock News brief for Thursday August 14th. Here are today's top headlines: Surf Air Mobility (NYSE: SRFM) participated in Electra's first demonstration flights of its EL2 Ultra Short aircraft at Virginia Tech, which achieved takeoffs and landings in under 150 feet and showcased its ability to operate from unconventional locations.

image for news Surf Air Mobility ($SRFM) | Aduro Clean Technologies ($ADUR) | FTC Solar ($FTCI) | Momentus ($MNTS)

With 96 Recalls, Ford's EV Plan in Doubt — Negative

F   24/7 Wall Street — August 14, 2025

Ford Motor Co. (NYSE: F) CEO Jim Farley said plans to build a new manufacturing system to produce its next-generation electric vehicle (EV) present a risk.

image for news With 96 Recalls, Ford's EV Plan in Doubt

LAS VEGAS, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Jet.AI Inc. ( “Jet.AI” or the “Company”) (Nasdaq: JTAI), a provider of high-performance GPU infrastructure and AI cloud services, today announced it has made a capital contribution to AIIA Sponsor Ltd. (“Sponsor”) which serves as the sponsor of AI Infrastructure Acquisition Corp., a special purpose acquisition company. On August 13, 2025, AI Infrastructure Acquisition Corp. filed a Registration Statement on Form S-1 (the "Registration Statement") with the Securities and Exchange Commission ("SEC") in connection with a proposed initial public offering of its units.

image for news Jet.AI Inc. Announces Strategic Capital Contribution to AIIA Sponsor Ltd., the Sponsor of a SPAC Organized to Pursue AI, Machine Learning, and Data Center Operations

Live video webcast on Wednesday, August 20 th at 2:20 PM ET LA JOLLA, CA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, that it will present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech being held virtually August 19-21, 2025. Details for the presentation are as follows: Date and Time: Wednesday, August 20, 2025 at 2:20 PM ET Presenter: Marc Hertz, PhD, President, Chief Executive Officer and …

image for news GRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

SOUTH SAN FRANCISCO, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that it will present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech being held virtually August 19-21, 2025.

image for news Senti Biosciences to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech